FOR THE RECORD

The Pathways trial rests on the unexamined assumption that childhood “gender identity” is an innate, medicalisable entity. Child development science – from Piaget to Winnicott – demonstrates the opposite.

The Cass Review also recommended a follow up to the 2000 children already prescribed puberty blockers through GIDS in England since 2014: There was no long-term follow up of the health outcomes for these children who will now be young adults. We still don’t have this data and my view is that it would be unethical to give these drugs to more children when we have limited information about the long term affects of their use.